| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.902 | 0.004 | 0.902 | Antiadrenergic | 0.885 0.004 DBMET00311 | ||
| 0.902 | 0.004 | 0.902 | Adrenaline antagonist | 0.884 0.004 DBMET00311 | ||
| 0.849 | 0.003 | 0.849 | Vasodilator, peripheral | 0.698 0.006 DBMET00311 | ||
| 0.747 | 0.005 | 0.747 | Cardiotonic | 0.679 0.005 DBMET00311 | ||
| 0.726 | 0.005 | 0.726 | Spasmolytic | 0.542 0.019 DBMET00311 | ||
| 0.676 | 0.002 | 0.676 | Beta adrenoreceptor antagonist | 0.559 0.002 DBMET00311 | ||
| 0.578 | 0.009 | 0.578 | Vasodilator, coronary | 0.442 0.025 DBMET00311 | ||
| 0.568 | 0.007 | 0.568 | Psychostimulant | 0.283 0.047 DBMET00311 | ||
| 0.54 | 0.009 | 0.54 | Vasodilator | 0.477 0.014 DBMET00311 | ||
| 0.511 | 0.002 | 0.511 | Beta 1 adrenoreceptor antagonist | 0.473 0.002 DBMET00311 | ||
| 0.492 | 0.002 | 0.492 | Adrenaline agonist | 0.442 0.003 DBMET00311 | ||
| 0.509 | 0.028 | 0.509 | Antithrombotic | 0.319 0.077 DBMET00311 | ||
| 0.469 | 0.002 | 0.49 | Beta 3 adrenoreceptor antagonist | 0.49 0.002 DBMET00311 | DBMET00311 | |
| 0.495 | 0.03 | 0.495 | Histamine release inhibitor | 0.264 0.145 DBMET00311 | ||
| 0.49 | 0.031 | 0.49 | Calcium channel L-type activator | 0.364 0.107 DBMET00311 | ||
| 0.403 | 0.016 | 0.403 | Cyclic AMP phosphodiesterase inhibitor | 0.192 0.1 DBMET00311 | ||
| 0.361 | 0.002 | 0.361 | Beta 2 adrenoreceptor antagonist | 0.356 0.002 DBMET00311 | ||
| 0.416 | 0.082 | 0.416 | Cyclophilin D inhibitor | 0.294 0.168 DBMET00311 | ||
| 0.345 | 0.012 | 0.345 | Alpha adrenoreceptor antagonist | 0.101 0.056 DBMET00311 | ||
| 0.363 | 0.032 | 0.365 | Sodium/bile acid cotransporter inhibitor | 0.365 0.031 DBMET00311 | DBMET00311 | |
| 0.324 | 0.002 | 0.324 | Beta adrenoreceptor agonist | 0.258 0.002 DBMET00311 | ||
| 0.35 | 0.029 | 0.35 | Interleukin agonist | 0.211 0.11 DBMET00311 | ||
| 0.366 | 0.079 | 0.366 | Antiobesity | 0.269 0.14 DBMET00311 | ||
| 0.286 | 0.014 | 0.286 | Anesthetic local | 0.278 0.015 DBMET00311 | ||
| 0.284 | 0.025 | 0.284 | Diuretic | 0.147 0.08 DBMET00311 | ||
| 0.277 | 0.018 | 0.277 | Interleukin 6 antagonist | 0.205 0.038 DBMET00311 | ||
| 0.361 | 0.106 | 0.361 | 5 Hydroxytryptamine release inhibitor | |||
| 0.259 | 0.014 | 0.259 | Alpha 1 adrenoreceptor antagonist | |||
| 0.27 | 0.036 | 0.27 | P-glycoprotein inhibitor | 0.221 0.052 DBMET00311 | ||
| 0.233 | 0.002 | 0.25 | Calcium-sensing receptor antagonist | 0.25 0.002 DBMET00311 | DBMET00311 | |
| 0.267 | 0.045 | 0.267 | Sigma receptor agonist | 0.184 0.067 DBMET00311 | ||
| 0.294 | 0.078 | 0.294 | Interleukin 2 agonist | 0.204 0.182 DBMET00311 | ||
| 0.215 | 0.002 | 0.215 | Beta 1 adrenoreceptor agonist | 0.14 0.002 DBMET00311 | ||
| 0.263 | 0.057 | 0.263 | Interleukin antagonist | |||
| 0.217 | 0.016 | 0.238 | Bronchodilator | 0.238 0.014 DBMET00311 | DBMET00311 | |
| 0.241 | 0.04 | 0.241 | Insulin sensitizer | 0.227 0.05 DBMET00311 | ||
| 0.209 | 0.01 | 0.209 | Adenylate cyclase stimulant | 0.193 0.017 DBMET00311 | ||
| 0.211 | 0.013 | 0.211 | NMDA receptor antagonist | 0.118 0.036 DBMET00311 | ||
| 0.201 | 0.016 | 0.201 | Alpha 1a adrenoreceptor antagonist | |||
| 0.187 | 0.002 | 0.187 | Beta 3 adrenoreceptor agonist | 0.106 0.003 DBMET00311 | ||
| 0.195 | 0.015 | 0.195 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.223 | 0.044 | 0.223 | Lipocortins synthesis antagonist | |||
| 0.207 | 0.027 | 0.207 | Calcium channel blocker | 0.107 0.105 DBMET00311 | ||
| 0.188 | 0.015 | 0.188 | Calcium antagonist | 0.086 0.059 DBMET00311 | ||
| 0.225 | 0.054 | 0.225 | Nitric-oxide synthase stimulant | 0.17 0.154 DBMET00311 | ||
| 0.203 | 0.034 | 0.203 | Insulin secretagoues | 0.135 0.09 DBMET00311 | ||
| 0.273 | 0.109 | 0.273 | Cholesterol antagonist | 0.191 0.173 DBMET00311 | ||
| 0.179 | 0.017 | 0.179 | Alpha 1b adrenoreceptor antagonist | |||
| 0.249 | 0.089 | 0.249 | 5 Hydroxytryptamine release stimulant | |||
| 0.176 | 0.034 | 0.176 | Nav1.3 sodium channel blocker | 0.128 0.066 DBMET00311 | ||
| 0.231 | 0.089 | 0.231 | Tyrosine 3 hydroxylase inhibitor | 0.184 0.168 DBMET00311 | ||
| 0.173 | 0.033 | 0.173 | Nav1.6 sodium channel blocker | 0.121 0.095 DBMET00311 | ||
| 0.322 | 0.184 | 0.322 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.147 | 0.01 | 0.147 | Phosphodiesterase III inhibitor | 0.117 0.016 DBMET00311 | ||
| 0.137 | 0.003 | 0.137 | Beta 2 adrenoreceptor agonist | 0.119 0.004 DBMET00311 | ||
| 0.263 | 0.132 | 0.263 | Calcium channel activator | |||
| 0.165 | 0.039 | 0.166 | MAP kinase kinase 4 inhibitor | 0.166 0.037 DBMET00311 | DBMET00311 | |
| 0.15 | 0.024 | 0.15 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.309 | 0.184 | 0.342 | Caspase 9 stimulant | 0.342 0.152 DBMET00311 | DBMET00311 | |
| 0.188 | 0.064 | 0.188 | Growth hormone agonist | 0.148 0.089 DBMET00311 | ||
| 0.14 | 0.016 | 0.14 | Alpha 1d adrenoreceptor antagonist | |||
| 0.208 | 0.089 | 0.212 | Peptidyltransferase inhibitor | 0.212 0.085 DBMET00311 | DBMET00311 | |
| 0.184 | 0.077 | 0.225 | DNA methyltransferase I inhibitor | 0.225 0.058 DBMET00311 | DBMET00311 | |
| 0.121 | 0.016 | 0.121 | Calcium channel L-type blocker | |||
| 0.141 | 0.037 | 0.141 | Nav1.1 sodium channel blocker | |||
| 0.237 | 0.137 | 0.237 | Transcription factor NF kappa B inhibitor | 0.191 0.178 DBMET00311 | ||
| 0.121 | 0.021 | 0.121 | Keratolytic | 0.118 0.022 DBMET00311 | ||
| 0.126 | 0.03 | 0.126 | Androgen antagonist | 0.077 0.069 DBMET00311 | ||
| 0.186 | 0.091 | 0.186 | MAP kinase kinase 2 inhibitor | |||
| 0.164 | 0.069 | 0.164 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.103 | 0.009 | 0.103 | Gonadotropin-releasing hormone receptor agonist | 0.081 0.017 DBMET00311 | ||
| 0.186 | 0.094 | 0.186 | Anticonvulsant | |||
| 0.215 | 0.126 | 0.215 | Gastrin inhibitor | |||
| 0.147 | 0.059 | 0.147 | Nav1.2 sodium channel blocker | |||
| 0.092 | 0.007 | 0.092 | Sphingosine 1-phosphate receptor 3 agonist | 0.091 0.007 DBMET00311 | ||
| 0.162 | 0.082 | 0.17 | ATPase inhibitor | 0.17 0.071 DBMET00311 | DBMET00311 | |
| 0.223 | 0.147 | 0.223 | Ca(v)3.3 blocker | 0.202 0.189 DBMET00311 | ||
| 0.182 | 0.115 | 0.182 | Aldehyde oxidase inhibitor | |||
| 0.168 | 0.102 | 0.194 | DNA methylase inhibitor | 0.194 0.083 DBMET00311 | DBMET00311 | |
| 0.102 | 0.039 | 0.115 | Glutamate release inhibitor | 0.115 0.026 DBMET00311 | DBMET00311 | |
| 0.109 | 0.05 | 0.109 | Anabolic | 0.101 0.061 DBMET00311 | ||
| 0.077 | 0.018 | 0.077 | Calcium channel P-type blocker | 0.06 0.058 DBMET00311 | ||
| 0.105 | 0.05 | 0.105 | MAP kinase kinase 1 inhibitor | |||
| 0.115 | 0.064 | 0.115 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.063 | 0.014 | 0.063 | Sphingosine 1-phosphate receptor agonist | 0.045 0.03 DBMET00311 | ||
| 0.068 | 0.019 | 0.068 | 5 Hydroxytryptamine 1B agonist | |||
| 0.181 | 0.133 | 0.181 | Hypoglycemic | |||
| 0.108 | 0.06 | 0.108 | Mediator release inhibitor | |||
| 0.1 | 0.052 | 0.1 | Phosphodiesterase 6D inhibitor | |||
| 0.059 | 0.013 | 0.059 | Sphingosine 1-phosphate receptor 1 agonist | 0.045 0.025 DBMET00311 | ||
| 0.219 | 0.178 | 0.219 | Immunosuppressant | |||
| 0.168 | 0.127 | 0.168 | Platelet antagonist | |||
| 0.106 | 0.069 | 0.106 | Mucolytic | 0.1 0.077 DBMET00311 | ||
| 0.049 | 0.014 | 0.049 | Growth hormone releasing factor agonist | |||
| 0.108 | 0.073 | 0.108 | Calcium channel (voltage-sensitive) blocker | |||
| 0.119 | 0.087 | 0.119 | Bone formation stimulant | |||
| 0.112 | 0.08 | 0.112 | Aldehyde dehydrogenase inhibitor | |||
| 0.126 | 0.094 | 0.126 | Peroxidase inhibitor | |||
| 0.061 | 0.031 | 0.061 | Bombesin 3 receptor antagonist | |||
| 0.106 | 0.077 | 0.106 | CDK3/cyclin E inhibitor | |||
| 0.112 | 0.083 | 0.112 | Glutamate receptor antagonist | |||
| 0.069 | 0.041 | 0.069 | MDM2 inhibitor | |||
| 0.112 | 0.086 | 0.114 | Alpha-N-acetylglucosaminidase inhibitor | 0.114 0.084 DBMET00311 | DBMET00311 | |
| 0.168 | 0.143 | 0.168 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.097 | 0.075 | 0.097 | Factor V inhibitor | |||
| 0.084 | 0.062 | 0.084 | Hematopoietic | |||
| 0.046 | 0.026 | 0.046 | HIV-1 protease inhibitor | 0.044 0.029 DBMET00311 | ||
| 0.094 | 0.075 | 0.094 | Expectorant | 0.087 0.086 DBMET00311 | ||
| 0.042 | 0.023 | 0.042 | Vascular adhesion protein 1 inhibitor | |||
| 0.113 | 0.096 | 0.113 | Cytokine production inhibitor | |||
| 0.028 | 0.011 | 0.028 | Growth hormone release promoting | |||
| 0.03 | 0.013 | 0.03 | Dopamine autoreceptor agonist | |||
| 0.051 | 0.041 | 0.051 | Cathepsin D inhibitor | |||
| 0.055 | 0.047 | 0.055 | Bombesin 1 receptor agonist | |||
| 0.021 | 0.016 | 0.021 | Follicle-stimulating hormone agonist | |||
| 0.154 | 0.151 | 0.154 | Immunostimulant | |||
| 0.084 | 0.082 | 0.084 | UDP-glucose 4-epimerase inhibitor | |||
| 0.083 | 0.082 | 0.083 | Protease inhibitor | |||
| 0.159 | 0.158 | 0.159 | ErbB-1 antagonist | |||
| 0.055 | 0.083 | 0.083 | Topoisomerase II alpha inhibitor | 0.083 0.051 DBMET00311 | DBMET00311 | |
| 0.047 | 0.081 | 0.097 | Phenylalanine 4-hydroxylase inhibitor | 0.097 0.027 DBMET00311 | DBMET00311 | |
| 0.029 | 0.098 | 0.056 | Alcohol oxidase inhibitor | 0.056 0.039 DBMET00311 | DBMET00311 | |
| 0.117 | 0.196 | 0.161 | Free radical scavenger | 0.161 0.132 DBMET00311 | DBMET00311 | |
| 0.114 | 0.221 | 0.168 | Antioxidant | 0.168 0.144 DBMET00311 | DBMET00311 | |
| 0.036 | 0.276 | 0.105 | Chelator | 0.105 0.071 DBMET00311 | DBMET00311 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |